July 21, 2010

Another Coffin Nail for Avandia

The suspension follows the suspension of the TIDE trial in India, July 14, at the request of

Read More
Another Coffin Nail for Avandia

July 15, 2010

Will Another Blockbuster Drug Hit the Dust?

In 2007, an FDA advisory panel voted 22 to 1 to keep GlaxoSmithKline’s diabetes drug, Avandia (Rosiglitazone)

Read More
Will Another Blockbuster Drug Hit the Dust?

July 10, 2010

Devastating FDA Safety Review of Avandia

Until now, FDA officials in the all-powerful center for new drug evaluation (called CEDER), have, for the

Read More
Devastating FDA Safety Review of Avandia

April 13, 2010

Corrupted Science–BMJ Review Examines Avandia Literature

A systematic review by researchers from the Mayo Clinic assessed bias in 202 published reports, reviews and

Read More
Corrupted Science–BMJ Review Examines Avandia Literature

March 6, 2010

Washington Times Response to AHRP

The Washington Times made the following editorial announcements: here and here.   "Had the Times known these

Read More
Washington Times Response to AHRP

March 5, 2010

Shame on the editors of the Washington Times!

Were the editors of the Washington Times asleep at the helm when they disseminated an OpEd tirade

Read More
Shame on the editors of the Washington Times!

February 24, 2010

Drug Casualties Continue to Increase_Quarterwatch

According to the database maintained by the National Highway Safety Administration there were 34 deaths alleged to

Read More
Drug Casualties Continue to Increase_Quarterwatch

February 22, 2010

Avandia Face-Off_GSK–Dr. Steven Nissen

The New York Times reports (below) that in May 2007, days before his Avandia safety study was

Read More
Avandia Face-Off_GSK–Dr. Steven Nissen

July 29, 2009

Pfizer-Neurontin Trial Testimony:”snake-oil list”

In 2004, Pfizer settled an illegal Neurontin marketing case with the U.S. Justice Department for $430 million. 

Read More
Pfizer-Neurontin Trial Testimony:”snake-oil list”

July 25, 2009

ACRE–A High Powered Harvard Stealth Pharma Front Group

Daniel Carlat, MD , is Associate Clinical Professor of Psychiatry Tufts University School of Medicine Publisher and

Read More
ACRE–A High Powered Harvard Stealth Pharma Front Group

April 30, 2009

Senator Grassley Might Leave Finance Committee: A Break For Pharma?

The Hill , a newspaper covering congressional news, reports: "Sen. Chuck Grassley (Iowa) is considering leaving his

Read More
Senator Grassley Might Leave Finance Committee: A Break For Pharma?

November 30, 2007

Letter of Complaint to FDA Commissioner, 2007

                                 ALLIANCE FOR HUMAN RESEARCH PROTECTION   www.ahrp.org 142 West End Avenue, Suite 28P New York, NY

Read More
Letter of Complaint to FDA Commissioner, 2007

October 26, 2006

GlaxoSmithKline CEO: "We had to absorb a number of hits"

GlaxoSmithKline CEO: “We had to absorb a number of hits” Mon, 16 Feb 2004 Antidepressant drug safety

Read More
GlaxoSmithKline CEO: "We had to absorb a number of hits"